Author

Jo Kitchen

Observed institutions: King's College London, Royal Berkshire Hospital, Royal Berkshire NHS Foundation Trust

OpenAlex ID: A5039850363

Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial

2024 · Andrew P Cope, Marianna Jasenecova, et al. · The Lancet · 207

Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial

2026 · Andrew P Cope, Marianna Jasenecova, et al. · The Lancet Rheumatology · 15

072 Patient perceptions of switching to biosimilars

2018 · Tagrid Hoque, Anam Suddle, et al. · Rheumatology · 4

Works count: 3

Citation count: 226

H-index: 3

I10-index: 2